Ulrike Lorch

8PUBLICATIONS
18CO-AUTHORS
SurgeryPharmacogenomicsCheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologiesNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 17, 2024
The safety of early phase clinical trials: Bridging the gap between governance and practice.

Ulrike Lorch, Charles Vincent

|Jun 02, 2021
Concentration-QT modelling of the novel DHFR inhibitor P218 in healthy male volunteers.

Jӧrg Täubel, Ulrike Lorch, Georg Ferber

|Jan 12, 2020
First-in-human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection.

M Farouk Chughlay, Emilie Rossignol, Cristina Donini

Pageof 2